Regulation of Viral Replication and Cellular Antiviral Mechanisms by Components of SWI/SNF Complex

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 512

Special Issue Editor


E-Mail Website
Guest Editor
Department of Genetics, Albert Einstein College of Medicine, New York, NY 10461, USA
Interests: INI1/SMARCB1 in HIV-1; SARS-CoV2 and cancer

Special Issue Information

Dear Colleagues,

SWI/SNF is a prototypic ATP-dependent multiprotein chromatin remodelling complex. It is conserved in all eukaryotes and functions as an epigenetic regulator modulating the transcription of multiple genes involved in development, cell cycle regulation and disease. Many of the components of this complex are tumour suppressors frequently mutated in human cancers. Components of SWI/SNF complex directly or indirectly interact with viral components and influence replication of several viruses including HIV-1, EBV2, HPV17 and SARS-CoV2 and have been shown to exert multifaceted roles in the replication of some of these viruses. Furthermore, SWI/SNF complex also has a role in regulating transcription of interferon signalling genes. How these varied functions of SWI/SNF complex modulates viral replication is not completely understood. This special issue is an effort to bring together what is known about the role of components of SWI/SNF chromatin remodelling complexes in various stages of viral replication to gain insight into how viruses may exploit this machinery for their own purpose. Studies to understand the role of components of SWI/SNF in viral replication may provide a window into some of the unprecedented functions of these complexes and may lead to novel strategies to inhibit viral replication.

Prof. Dr. Ganjam V Kalpana
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • SWI/SNF
  • BAF complex
  • INI1/SMARCB1
  • BRG1/SMARCA4
  • BRM/SMARCA2
  • viruses
  • transcription
  • late events
  • early events
  • particle morphogenesis
  • RNA mimicry
  • chroimatin remodeling
  • interferon signalling

Published Papers

This special issue is now open for submission.
Back to TopTop